Vol 58, No 4 (2007)
Review paper
Published online: 2007-05-17

open access

Page views 650
Article views/downloads 7039
Get Citation

Connect on Social Media

Connect on Social Media

Natriuretic peptides: their role in diagnosis and therapy

Dorota Pakuła, Bogdan Marek, Dariusz Kajdaniuk, Beata Kos-Kudła, Halina Borgiel-Marek, Robert Krysiak, Aleksander Gatnar, Piotr Pakuła
Endokrynol Pol 2007;58(4):364-375.

Abstract

Cardiac natriuretic peptide hormones, atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP), are synthesized and secreted by the heart, producing several biological effects, such as natriuresis, vasorelaxation and hypotension. During the last decade these peptides, especially BNP, have received increasing attention as potential markers of cardiovascular disease. Their measurements can be used to diagnose heart failure, including diastolic dysfunction, and using them has been shown to save money. BNP levels can enable the differentation between dyspnoic patients secondary to ventricular dysfunction and subjects with primary respiratory disorders. Moreover, there is good evidence that natriuretic peptides may have a diagnostic role in arterial hypertension, acute coronary syndromes, pulmonary hypertension, some valvular heart disease and some disorders affecting other systems (diabetes or thyroid disorders). In this paper we disscuss the clinical utility of assessment of natriuretic peptide hormones in the diagnosis of various clinical conditions and their use as pharmacological agents.
(Pol J Endocrinol 2007; 58 (4): 364-374)

Article available in PDF format

View PDF (Polish) Download PDF file